Prestige Consumer Healthcare PBH Stock
Prestige Consumer Healthcare Price Chart
Prestige Consumer Healthcare PBH Financial and Trading Overview
| Prestige Consumer Healthcare stock price | 80.95 USD |
| Previous Close | 57.32 USD |
| Open | 57.46 USD |
| Bid | 53.9 USD x 1000 |
| Ask | 62.42 USD x 1000 |
| Day's Range | 57.11 - 57.92 USD |
| 52 Week Range | 48.51 - 67.45 USD |
| Volume | 314.52K USD |
| Avg. Volume | 236.2K USD |
| Market Cap | 2.85B USD |
| Beta (5Y Monthly) | 0.554225 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 4.26 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | September 27, 2018 |
| 1y Target Est | 75.25 USD |
PBH Valuation Measures
| Enterprise Value | 4.16B USD |
| Trailing P/E | N/A |
| Forward P/E | 12.287554 |
| PEG Ratio (5 yr expected) | 1.69 |
| Price/Sales (ttm) | 2.5231311 |
| Price/Book (mrq) | 1.9662786 |
| Enterprise Value/Revenue | 3.686 |
| Enterprise Value/EBITDA | 10.927 |
Trading Information
Prestige Consumer Healthcare Stock Price History
| Beta (5Y Monthly) | 0.554225 |
| 52-Week Change | 4.54% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 67.45 USD |
| 52 Week Low | 48.51 USD |
| 50-Day Moving Average | 60.13 USD |
| 200-Day Moving Average | 58.94 USD |
PBH Share Statistics
| Avg. Volume (3 month) | 236.2K USD |
| Avg. Daily Volume (10-Days) | 261.61K USD |
| Shares Outstanding | 49.69M |
| Float | 49.36M |
| Short Ratio | 5.61 |
| % Held by Insiders | 0.82% |
| % Held by Institutions | 102.62% |
| Shares Short | 1.3M |
| Short % of Float | 3.64% |
| Short % of Shares Outstanding | 2.61% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -7.29% |
| Operating Margin (ttm) | 30.84% |
| Gross Margin | 56.11% |
| EBITDA Margin | 33.73% |
Management Effectiveness
| Return on Assets (ttm) | 6.18% |
| Return on Equity (ttm) | -5.44% |
Income Statement
| Revenue (ttm) | 1.13B USD |
| Revenue Per Share (ttm) | 22.61 USD |
| Quarterly Revenue Growth (yoy) | 7.09% |
| Gross Profit (ttm) | N/A |
| EBITDA | 380.43M USD |
| Net Income Avi to Common (ttm) | -82306000 USD |
| Diluted EPS (ttm) | -1.63 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 58.49M USD |
| Total Cash Per Share (mrq) | 1.18 USD |
| Total Debt (mrq) | 1.37B USD |
| Total Debt/Equity (mrq) | 94.47 USD |
| Current Ratio (mrq) | 2.438 |
| Book Value Per Share (mrq) | 29.121 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 229.72M USD |
| Levered Free Cash Flow (ttm) | 165.23M USD |
Profile of Prestige Consumer Healthcare
| Country | United States |
| State | NY |
| City | Tarrytown |
| Address | 660 White Plains Road |
| ZIP | 10591 |
| Phone | 914 524 6800 |
| Website | https://www.prestigebrands.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 560 |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Q&A For Prestige Consumer Healthcare Stock
What is a current PBH stock price?
Prestige Consumer Healthcare PBH stock price today per share is 80.95 USD.
How to purchase Prestige Consumer Healthcare stock?
You can buy PBH shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Prestige Consumer Healthcare?
The stock symbol or ticker of Prestige Consumer Healthcare is PBH.
Which industry does the Prestige Consumer Healthcare company belong to?
The Prestige Consumer Healthcare industry is Drug Manufacturers-Specialty & Generic.
How many shares does Prestige Consumer Healthcare have in circulation?
The max supply of Prestige Consumer Healthcare shares is 49.54M.
What is Prestige Consumer Healthcare Price to Earnings Ratio (PE Ratio)?
Prestige Consumer Healthcare PE Ratio is 19.00234600 now.
What was Prestige Consumer Healthcare earnings per share over the trailing 12 months (TTM)?
Prestige Consumer Healthcare EPS is 4.26 USD over the trailing 12 months.
Which sector does the Prestige Consumer Healthcare company belong to?
The Prestige Consumer Healthcare sector is Healthcare.
Prestige Consumer Healthcare PBH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq US 700 Small Cap Value N NQUS700SCVN | 2120.89 USD — |
+0.33
|
— — | 2098.01 USD — | 2131.17 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2076.39 USD — |
+0.55
|
— — | 2051.38 USD — | 2085.49 USD — | — - | — — |
| NYSE COMPOSITE (DJ) NYA | 18971.73 USD — |
+0.38
|
— — | 18822.43 USD — | 19030.68 USD — | — - | — — |
| Nasdaq US 700 Small Cap Value I NQUS700SCV | 1884.11 USD — |
+0.33
|
— — | 1863.79 USD — | 1893.25 USD — | — - | — — |
| Nasdaq US Smart Pharmaceuticals NQSSPH | 1352.76 USD — |
+1.11
|
— — | 1340.2 USD — | 1356.44 USD — | — - | — — |
- {{ link.label }} {{link}}